778
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

The effect of educational intervention on use of psychotropics in defined daily doses and related costs – a randomized controlled trial

, , , &
Pages 246-252 | Received 16 Nov 2021, Accepted 31 Jan 2022, Published online: 12 May 2022

References

  • By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American geriatrics society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674–694.
  • Tampi RR, Tampi DJ, Balachandran S, et al. Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses. Ther Adv Chronic Dis. 2016;7(5):229–245.
  • Liperoti R, Sganga F, Landi F, et al. Antipsychotic drug interactions and mortality among nursing home residents with cognitive impairment. J Clin Psychiatry. 2017;78(1):e76–e82.
  • Seppälä LJ, Wermelink AMAT, de Vries M, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc. 2018;19(4):371.e11–371.e17.
  • Foebel AD, Liperoti R, Onder G, et al. Use of antipsychotic drugs among residents with dementia in European long-term care facilities: results from the SHELTER study. J Am Med Dir Assoc. 2014;15(12):911–917.
  • Janus SI, van Manen JG, IJzerman MJ, et al. Psychotropic drug prescriptions in Western European Nursing Homes. Int Psychogeriatr. 2016;28(11):1775–1790.
  • Roitto HM, Kautiainen H, Aalto UL, et al. Fourteen-Year trends in the use of psychotropic medications, opioids, and other sedatives among institutionalized older people in Helsinki, Finland. J Am Med Dir Assoc. 2019;20(3):305–311.
  • Jester DJ, Molinari V, Zgibor JC, et al. Prevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis. Int Psychogeriatr. 2021;7:1–16.
  • Hill-Taylor B, Sketris I, Hayden J, et al. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013;38(5):360–372.
  • Hyttinen V, Jyrkkä J, Valtonen H. A systematic review of the impact of potentially inappropriate medication on health care utilization and costs among older adults. Med Care. 2016;54(10):950–964.
  • Harrison SL, Kouladjian O'Donnell L, Milte R, et al. Costs of potentially inappropriate medication use in residential aged care facilities. BMC Geriatr. 2018;18(1):9.
  • Finnish statistics on medicines 2019. Finnish Medicines Agency Fimea and Social Insurance Institution. Helsinki 2020. ISSN 2490-0109.
  • Social insurance institution of Finland 2021. Medicinal Products Database. [cited 2021 March 19]. Available from: https://asiointi.kela.fi/laakekys_app/LaakekysApplication/Valmisteet.
  • Harrison SL, Cations M, Jessop T, et al. Approaches to deprescribing psychotropic medications for changed behaviours in long-term care residents living with dementia. Drugs Aging. 2019;36(2):125–136.
  • Pitkälä KH, Juola AL, Kautiainen H, et al. Education to reduce potentially harmful medication use among residents of assisted living facilities: a randomized controlled trial. J Am Med Dir Assoc. 2014;15(12):892–898.
  • Fog AF, Kvalvaag G, Engedal K, et al. Drug-related problems and changes in drug utilization after medication reviews in nursing homes in Oslo, Norway. Scand J Prim Health Care. 2017;35(4):329–335.
  • Massot Mesquida M, Tristany Casas M, Franzi Sisó A, et al. Consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients. BMC Geriatr. 2019;19(1):7.
  • Wauters M, Elseviers M, Peeters L, et al. Reducing psychotropic drug use in nursing homes in Belgium: an implementation study for the roll-out of a practice improvement initiative. Drugs Aging. 2019;36(8):769–780.
  • Morris JN, Fries BE, Bernabei R, et al. RAI-home care (RAI-HC) assessment manual for version 2.0. 2000. Marblehead, MA: Opus Communications.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
  • Folstein MF, Folstein SE, McHugh PR. Mini-mental state". a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
  • Guigoz Y, Lauque S, Vellas BJ. Vellas BJ: Identifying the elderly at risk for malnutrition. The mini nutritional assessment. Clin Geriatr Med. 2002;18(4):737–757.
  • WHO Collaborating Centre for Drug Statistics Methodology: Anatomical therapeutic chemical classification system. ATC/DDD Index 2012. [http://www.whocc.no/atc_ddd_index/.] Accessed 1 March 2015.
  • Renbase – drug dosing in renal failure. [cited 2017 June 29]. Available from: http://www.terveysportti.fi/terveysportti/renbase.koti.
  • SFINX Drug interactions Swedish, Finnish, INteraction X-referencing database. [cited 2015 August 25]. Available from: http://www.terveysportti.fi/terveysportti/interaktio.sfinxpharao.koti#.
  • Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339(1):b3692–b3692.
  • You JJ, Singer DE, Howard PA, et al. American college of chest physicians. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e531S–e575S.
  • Finnish statistics on medicines 2012. Finnish Medicines Agency Fimea and Social Insurance Institution. Helsinki 2013. ISSN 0786-2180.
  • Sterke CS, van Beeck EF, van der Velde N, et al. New insights: dose-response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia. J Clin Pharmacol. 2012;52(6):947–955.